Drugs / NTZ 500mg BID on top of SOC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07694297 | Oct 2026 → Aug 2027 expected | liver failure | Genfit | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NTZ 500mg BID on top of SOC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07694297 ↗ |